FDA Approves Nasacort AQ For Children

The U.S. Food and Drug Administration (FDA) has approved Sanofi-aventis’ Nasacort AQ® Nasal Spray (triamcinolone acetonide) for children two to five years of age for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis (Medical News Today).

Latest posts by admin aapc (see all)

Leave a Reply

Your email address will not be published. Required fields are marked *